Citations

Mayo Clinic

Clear

1 citation(s) found for "Sahre, Martina".

Evaluating Patients With Impaired Renal Function During Drug Development: Highlights From the 2019 US FDA Pharmaceutical Science and Clinical Pharmacology Advisory Committee Meeting
Sahre, Martina , Milligan, Lauren, Madabushi, Rajanikanth , Graham, Richard, Reynolds, Kellie S., Benjamin, Jessica M., Burckart, Gilbert J. , Schuck, Robert N. , Thompson, Aliza M., Zineh, Issam, Terzic, André , Huang, Shiew‐Mei

Clinical Pharmacology & Therapeutics | January 10, 2021 | Volume: 110 | Issue: 2 | Pages: 285-288

10.1002/cpt.2151 | PMID 33411946 Get It

Patients with multiple chronic conditions, including more advanced chronic kidney disease (CKD), are often excluded from clinical trials, creating challenges in deriving appropriate dosing information and labeling. This article summarizes the May 7, 2019, US Food and Drug Administration Pharmaceutical Science and Clinical Pharmacology Advisory Committee Meeting, which solicited expert opinions on how to enroll patients with more advanced CKD into clinical trials as well as the assumptions behind and different approaches of exposure‐matching.